Physician profile
Harrison Phu Nguyen
NPI 1205333887
$803,855.05
in general payments reported to CMS, 2019-2025
41 companies · $575K in 2025
The $575K reported for 2025 was more than what 99% of Dermatology providers received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $52.89 · 2022: $1,528 · 2023: $3,674 · 2024: $223K · 2025: $575K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $428K · Consulting Fee: $235K · Travel and Lodging: $58K · Food and Beverage: $33K · Honoraria: $33K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $16K · Education: $119.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $427,816.63 |
| Consulting Fee | $235,181.88 |
| Travel and Lodging | $57,609.36 |
| Food and Beverage | $32,967.73 |
| Honoraria | $32,700.00 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $15,880.00 |
| Education | $118.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $139,321.39 | 2023-2025 | Tremfya |
| Galderma Laboratories, L.P. | $97,232.24 | 2024-2025 | Nemluvio, Aklief, Dysport |
| Amgen INC. | $85,585.73 | 2020-2025 | Otezla, Otezla |
| Leo Pharma INC. | $78,346.61 | 2023-2025 | Adbry, Anzupgo, Spevigo |
| Ucb, INC. | $67,121.02 | 2024-2025 | Bimzelx |
| Pfizer INC. | $63,257.64 | 2023-2025 | |
| Sun Pharmaceutical Industries INC. | $55,679.79 | 2022-2025 | Ilumya, Absorica Ld, Winlevi |
| Organon LLC | $50,560.78 | 2025 | Vtama |
| Incyte Corporation | $36,994.40 | 2022-2025 | Opzelura, Opzelura |
| Novartis Pharmaceuticals Corporation | $29,373.71 | 2023-2025 | |
| Regeneron Healthcare Solutions, INC. | $17,400.21 | 2023-2025 | Libtayo, Dupixent |
| Takeda Pharmaceuticals U.S.A., INC. | $11,905.36 | 2025 | |
| Verrica Pharmaceuticals INC. | $11,640.41 | 2024 | Ycanth |
| Abbvie INC. | $10,643.46 | 2022-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $9,456.95 | 2022-2025 | Spevigo |
Show all 41 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dermavant Sciences, INC. | $8,208.03 | 2023-2024 | Vtama |
| Arcutis Biotherapeutics, INC. | $6,533.90 | 2023-2025 | Zoryve |
| E.R. Squibb & Sons, L.L.C. | $6,098.57 | 2022-2025 | Sotyktu, Sprycel |
| Johnson & Johnson Health Care Systems INC. | $4,800.00 | 2024 | |
| Janssen Scientific Affairs, LLC | $4,757.90 | 2024-2025 | Tremfya |
| Genzyme Corporation | $4,641.57 | 2023-2025 | |
| Boehringer Ingelheim International Gmbh | $1,967.81 | 2025 | |
| Revance Therapeutics, INC. | $377.77 | 2025 | Daxxify |
| Regeneron Pharmaceuticals, INC. | $320.60 | 2024 | Dupixent, Libtayo |
| Kerecis Limited | $272.41 | 2023-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $233.84 | 2025 | Cabtreo |
| Lumenis Be INC | $232.78 | 2025 | M22 |
| Lilly USA, LLC | $199.18 | 2023-2025 | Ebglyss, Taltz |
| Biofrontera INC. | $125.51 | 2023-2025 | Xepi, Bf-Rhodoled, Ameluz |
| Blueprint Medicines Corporation | $116.61 | 2025 | |
| Mayne Pharma Commercial LLC | $76.96 | 2023-2025 | |
| Convatec INC. | $74.76 | 2024-2025 | |
| Strata Skin Sciences, INC. | $53.94 | 2025 | Xtrac |
| Boehringer Ingelheim Pharma Gmbh & Co.Kg | $50.29 | 2025 | |
| Mimedx Group, INC. | $46.31 | 2025 | |
| Lnhc, INC | $36.18 | 2025 | Zelsuvmi |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $35.26 | 2025 | Cabtreo |
| Springworks Therapeutics, INC. | $23.04 | 2025 | Gomekli |
| Almirall LLC | $20.83 | 2025 | Seysara |
| Fidia Pharma USA INC. | $16.85 | 2024 | |
| Integra Lifesciences Corporation | $14.45 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Harrison Nguyen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.